In this randomized , double-blind , placebo-controlled study , healthy male subjects received an intravenous injection of either a moderate dose of LPS ( 0.8 ng/kg Escherichiacoli ) , low-dose LPS ( 0.4 ng/kg ) , or saline ( placebo control group ) .